Quantcast
Last updated on April 20, 2014 at 14:04 EDT

Latest Hepacivac Stories

2014-03-25 08:29:46

NEW YORK, March 25, 2014 /PRNewswire/ -- At the New York Viral Hepatitis Summit presented by the National Black Leadership Commission on AIDS, Inc. (NBLCA) on Thursday, March 20 at Harlem Hospital Center in New York City, medical experts, public health officials, and community health advocates discussed the latest medical research, diagnosis and treatment options, and community health implications of the Hepatitis C virus (HCV), emphasizing the disproportionate impact of HCV on the...

2014-03-06 08:30:17

Additional drug-drug interaction data for faldaprevir combined with commonly prescribed HIV medications also presented at CROI 2014 INGELHEIM, Germany and RIDGEFIELD, Conn., March 6, 2014 /PRNewswire/ -- Today Boehringer Ingelheim announced results from STARTVerso(®)4 in patients with HCV/HIV co-infection. Hepatitis C viral cure 12 weeks after the conclusion of treatment (SVR12) was achieved by 72% of all patients in the trial. Patients were enrolled in either 120mg or 240mg...

Hepatitis C Vaccine Efforts Bring Vaccine Closer To Reality
2013-11-30 05:22:41

redOrbit Staff & Wire Reports - Your Universe Online A hepatitis C vaccine is one step closer thanks to the efforts of scientists at The Scripps Research Institute (TSRI), who have managed to discover unexpected structural features of a protein used by the virus to infect liver cells. The study authors, whose work appears in Friday’s edition of the journal Science, state any successful hepatitis C vaccine would most likely target this protein, which is known as E2 envelope...

2013-11-26 08:28:12

MILFORD, Mass., Nov. 26, 2013 /PRNewswire/ -- Spring Bank Pharmaceuticals, Inc. of Milford, MA today announced the completion of the single ascending dose portion of their Ph. 1 clinical trial in healthy HCV infected patients and the start of the first cohort of the multiple ascending dose portion of the Phase 1 clinical trial in HCV patients. The trial is being conducted in Australia and New Zealand. The single ascending dose (SAD) stage of the trial was designed to demonstrate the...

2013-10-29 11:03:54

Infants who get hepatitis C from their mothers during childbirth may inherit a viral strain that replicates more quickly than strains found in non-pregnant hosts, according to a new study published Oct. 27 in Nature Medicine. The findings, from a team in The Research Institute at Nationwide Children's Hospital, are the first to describe how a virus that has infected 180 million people worldwide takes advantage of immune changes during pregnancy. About 1 percent of all pregnant women...

2013-09-21 00:20:06

This discovery gives hope for a more effective and cheaper treatment strategy to millions worldwide suffering from chronic infectionsSingapore, Sept 21, 2013 - (ACN Newswire) - A recent discovery by scientists at A*STAR's Singapore Institute for Clinical Sciences (SICS), in close collaboration with researchers at the Singapore Immunology Network (SIgN), provides hope for a new personalised treatment strategy that could use a patient's own blood to treat the infection....

2013-09-17 08:30:56

- Patent valid until at least 2031 - JERUSALEM, Sept. 17, 2013 /PRNewswire/ -- BioLineRx Ltd. (NASDAQ:BLRX) (TASE:BLRX), a biopharmaceutical development company, announced today that a Notice of Allowance has been issued by the United States Patent and Trademark Office (USPTO) for BL-8020, an orally available, interferon-free treatment for hepatitis C. The patent covers the use of BL-8020 for treating HCV-infected patients non-responsive to an anti-HCV therapy (patients who failed...

2013-08-05 23:17:34

System Represents Major Advance in Studying Virus New York, NY (PRWEB) August 05, 2013 By differentiating monkey stem cells into liver cells and inducing successful infection, researchers from the Icahn School of Medicine at Mount Sinai have shown for the first time that the hepatitis C virus (HCV) can replicate in monkeys, according to research published in the journal Gastroenterology. The new findings may lead to the first new animal model and provide new avenues for developing...

2013-08-05 08:01:27

System represents major advance in studying virus By differentiating monkey stem cells into liver cells and inducing successful infection, researchers from the Icahn School of Medicine at Mount Sinai have shown for the first time that the hepatitis C virus (HCV) can replicate in monkeys, according to research published in the journal Gastroenterology. The new findings may lead to the first new animal model and provide new avenues for developing treatments and vaccines for this disease,...

2013-07-24 16:24:45

NEW YORK, July 24, 2013 /PRNewswire/ -- On Thursday, July 25, 2013, the National Black Leadership Commission on AIDS, Inc. (NBLCA), in partnership with the Coalition for Positive Health Empowerment (COPE) and the Harm Reduction Coalition, is spearheading the first annual African American Hepatitis C Action Day, a national community mobilization initiative aimed at reducing the high incidence of HCV infection in black communities by drawing attention to this neglected health disparity...